FDAnews
www.fdanews.com/articles/146757-heart-damage-repaired-by-reprogramming-resident-fibroblasts-into-functioning-heart-cells

Heart Damage Repaired by Reprogramming Resident Fibroblasts Into Functioning Heart Cells

May 29, 2012
LoneStar Heart announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart muscle cells to treat damage following a heart attack and other forms of heart disease.
MarketWatch